{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T20:10:11Z","timestamp":1723925411701},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymgmr.2024.101113","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T03:16:40Z","timestamp":1719544600000},"page":"101113","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations"],"prefix":"10.1016","volume":"40","author":[{"given":"Lindsay","family":"Torrice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Jalazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgmr.2024.101113_bb0005","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2022.01.037","article-title":"Fluoxetine ameliorates mucopolysaccharidosis type IIIA","volume":"30","author":"Capuozzo","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101113_bb0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s13023-022-02484-6","article-title":"Sanfilippo syndrome: consensus guidelines for clinical care","volume":"17","author":"Muschol","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"21","key":"10.1016\/j.ymgmr.2024.101113_bb0015","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.3390\/ijms21217819","article-title":"Sanfilippo syndrome: molecular basis, disease models and therapeutic approaches","volume":"21","author":"Benet\u00f3","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101113_bb0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10545-013-9661-8","article-title":"Natural history of Sanfilippo syndrome type a","volume":"37","author":"Buhrman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101113_bb0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2016.08.002","article-title":"A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: implications for clinical trial design","volume":"119","author":"Truxal","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101113_bb0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A prospective natural history study of Mucopolysaccharidosis type IIIA","volume":"170","author":"Shapiro","year":"2016","journal-title":"J. Pediatr."},{"article-title":"Fluoxetine: pediatric drug information","year":"2023","series-title":"UpToDate","key":"10.1016\/j.ymgmr.2024.101113_bb0035"},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101113_bb0040","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S1734-1140(12)70927-1","article-title":"Drug therapy in autism: a present and future perspective","volume":"64","author":"Kumar","year":"2012","journal-title":"Pharmacol. Rep."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:35:27Z","timestamp":1723923327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":8,"alternative-id":["S2214426924000661"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101113","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101113"}}